Pfizer, Moderna and Covid-19

Moderna, Pfizer or Novavax? How the three Covid-19 vaccines differ according to Yale Medicine
In August, the Food and Drug Administration authorized updated vaccines against COVID-19. Here's what to know about the three vaccines available in the U.S.
Moderna disappoints in RSV debut, squares up with Pfizer in COVID-19 vaccine sales
Days after Pfizer and BioNTech reported surprisingly strong sales of their updated COVID-19 vaccines, Moderna has done the same. | Days after Pfizer and BioNTech reported surprisingly strong sales of their updated COVID-19 vaccines,
Pfizer, GSK, Moderna struggle in a shrinking RSV vaccine market
Q3 results confirms that the U.S. vaccine market for respiratory syncytial virus (RSV), led by Pfizer (PFE) and GSK (GSK), is shrinking. Read more here.
Pfizer sales of RSV vaccine ebb, but company gains market share
New guidelines and the timing of COVID vaccinations impacted uptake of Abrysvo this year, according to a company executive.
Canada approves Moderna's RSV vaccine for adults aged 60 and older
Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years and older, making it the country's first authorised mRNA-based shot for the condition.
Health Canada approves Moderna’s mRNA RSV vaccine, company says
Moderna says Health Canada has approved its mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older. The company says it expects the RSV vaccine — called mRESVIA — to be available in early 2025.
Fact Check: WHO didn't ‘admit’ monkeypox is a side effect of Pfizer’s COVID vaccine
Unverified data about events after vaccinations is not evidence that the vaccine caused the event, as suggested in social ...
devdiscourse6h
India's Vaccine Manufacturing Revolution: A Path to Safety and Transparency
India should focus on enhancing local vaccine manufacturing and research for better control over safety, according to GTRI. They also suggest investigating adverse health events post-vaccination to ...
Fox News12d
Rand Paul hits 'Biden/Harris CDC' over COVID-19 vaccine guidance for 6-month-olds
The Centers for Disease Control and Prevention's (CDC's) 2024-2025 COVID-19 vaccine immunization schedule advises, in the ...
Vaccine Stocks Drop on Worries About an RFK Jr. Role
It’s too early to know if Robert F. Kennedy Jr. will have an important healthcare role in a second Trump administration, but ...
Pfizer rides Paxlovid sales growth to better-than-expected third quarter
A boost from COVID-19 treatment sales helped bush Pfizer to a better-than-expected third quarter and higher forecast for the ...
Pfizer raises full-year guidance by $1.5 billion amid activist investor pressure
Pfizer ( PFE) raised its full-year guidance by $1.5 billion and posted strong third quarter earnings Tuesday. The company now ...
Pfizer Q3 Revenue, EPS Exceed Estimates
Pfizer reported an adjusted EPS of $1.06, exceeding estimates by over 72%. Revenue reached $17.7 billion, marking a 32% year ...
Pfizer: The Tide Finally Turning
Pfizer, a multinational pharmaceutical and biotechnology corporation, is now a $159 billion (by market cap) healthcare giant.